Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2386]

ECC 2015:  Results of international trial show promise in rare, difficult to treat cancer

ECC 2015:  Results of international trial show promise in rare, difficult to treat cancer

ECC 2015:  Rare cancer responds unusually well to new treatment: results from the NETTER-1 trial

ECC 2015:  Rare cancer responds unusually well to new treatment: results from the NETTER-1 trial

ECC 2015: Primary surgery is associated with survival benefit in patients with advanced cancers of the throat

ECC 2015: Primary surgery is associated with survival benefit in patients with advanced cancers of the throat

Study questions use of androgen deprivation therapy for certain prostate cancer cases

Study questions use of androgen deprivation therapy for certain prostate cancer cases

GI side effects of chemotherapy reduced in mice by targeting gut microbes

GI side effects of chemotherapy reduced in mice by targeting gut microbes

Study defines clinical trials likely to exclude patients with brain metastases

Study defines clinical trials likely to exclude patients with brain metastases

FDA OKs rolapitant for chemotherapy-induced nausea and vomiting

FDA OKs rolapitant for chemotherapy-induced nausea and vomiting

Apply for 3rd EurocanPlatform Summer School in Translational Cancer Research: Portugal, 12 – 16 October 2015

Apply for 3rd EurocanPlatform Summer School in Translational Cancer Research: Portugal, 12 – 16 October 2015

FDA approved sonidegib for locally advanced basal cell carcinoma

FDA approved sonidegib for locally advanced basal cell carcinoma

New technique for precise light-activated chemotherapy drugs

New technique for precise light-activated chemotherapy drugs

More from ecancer